| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Bretylium tosylate (substance) |
Is a |
False |
Bretylium (substance) |
Inferred relationship |
Some |
|
| Bretylium measurement |
Component |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Bretylium adverse reaction |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Allergy to bretylium (finding) |
Causative agent (attribute) |
False |
Bretylium (substance) |
Inferred relationship |
Some |
|
| Bretylium overdose |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Accidental bretylium overdose |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Intentional bretylium overdose |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Bretylium overdose of undetermined intent |
Causative agent (attribute) |
False |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Product containing bretylium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Breytlium tosylate 50mg/ml injection solution 400mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bretylium (substance) |
Inferred relationship |
Some |
|
| Breytlium tosylate 50mg/ml injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bretylium (substance) |
Inferred relationship |
Some |
|
| Breytlium tosylate 50mg/ml injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bretylium (substance) |
Inferred relationship |
Some |
|
| Allergy to bretylium (finding) |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Bretylium tosylate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Bretylium (substance) |
Inferred relationship |
Some |
|
| Bretylium-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Bretylium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Bretylium only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bretylium 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bretylium 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bretylium (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]